Melphalan

美法仑

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameMelphalan
Drug Alias Name苯丙氨酸氮芥Melphalanum左旋溶肉瘤素马尔法兰马法兰 +[13
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsUveal melanomaSkin MelanomaAmyloidosis +[19
Global Approved IndicationsOvarian NeoplasmsBreast NeoplasmsMultiple Myeloma +[4
Approved Indications in ChinaOvarian NeoplasmsBreast NeoplasmsMultiple Myeloma +[4
Original Approved Country/TerritoryCanada
Original Approved Date1963/01/01
Country/TerritoryCanadaUnited StatesNetherlands +[9
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApotex
China Registration ClassN/A

Develop Information

Active IndicationsUveal melanomaParaproteinemiasOvarian Neoplasms +[8
Inactive IndicationsSkin MelanomaAmyloidosisMyelodysplastic Syndromes +[11

Other Information

ATC CodeL01AA03